{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:09:13Z","timestamp":1778098153993,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jneuroim.2018.01.013","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T22:56:09Z","timestamp":1517612169000},"page":"5-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide"],"prefix":"10.1016","volume":"317","author":[{"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlene","family":"Alonso-Juarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.01.013_bb0005","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/jnnp.74.7.998","article-title":"Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus","volume":"74","author":"Antonini","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00702-017-1754-3","article-title":"Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review","volume":"124","author":"Baizabal-Carvallo","year":"2017","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12311-009-0109-5","article-title":"Asymmetry of cerebellar activation during vertical pursuit eye movements","volume":"8","author":"Glasauer","year":"2009","journal-title":"Cerebellum"},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/jnnp.2006.091116","article-title":"Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia","volume":"78","author":"Ishida","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0025","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1528-1167.2007.01500.x","article-title":"Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus","volume":"49","author":"Kanter","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0030","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/01.wnl.0000238389.83574.be","article-title":"Improvement with corticosteroids and azathioprine in GAD65-associated cerebellar ataxia","volume":"67","author":"McFarland","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/brain\/awh532","article-title":"Vertical nystagmus: clinical facts and hypotheses","volume":"128","author":"Pierrot-Deseilligny","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0040","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archneur.61.6.902","article-title":"Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity","volume":"61","author":"Rakocevic","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jns.2016.01.038","article-title":"Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations","volume":"362","author":"Shaikh","year":"2016","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jneuroim.2018.01.013_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2008.10.002","article-title":"Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome","volume":"32","author":"Skorstad","year":"2009","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0055","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00415-011-5999-8","article-title":"Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus","volume":"258","author":"Strupp","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0060","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1196\/annals.1325.042","article-title":"Potential role of anti-GAD antibodies in abnormal eye movements","volume":"1039","author":"Tilikete","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jns.2015.10.024","article-title":"Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies","volume":"359","author":"Vale","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.01.013_bb0070","first-page":"1985","article-title":"Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children","volume":"3","author":"Yule","year":"1997","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817304903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817304903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:30:22Z","timestamp":1759048222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817304903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":14,"alternative-id":["S0165572817304903"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.01.013","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}